Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
January 13, 2015
Patent Application Number
10786907
Date Filed
February 25, 2004
Patent Citations Received
Patent Primary Examiner
Patent abstract
Recombinant antibody-based molecules that trigger both T-cell and B-cell immune responses are disclosed. The recombinant molecules are comprised by at least one targeting unit and at least one antigenic unit connected through a dimerization motif. Also disclosed are nucleic acid molecules encoding the recombinant antibody-based molecule and methods of treating multiple myeloma or lymphoma in a patient using the recombinant antibody-based molecules or the nucleic acid molecules.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
